| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |